In this report, the United States Insulin market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.
Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Insulin in these regions, from 2013 to 2025 (forecast).
United States Insulin market competition by top manufacturers/players, with Insulin sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Novo Nordisk
Sanofi
Eli Lilly
Bioton
Dongbao
Gan & Lee
United Laboratories (TUL)
...
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Short-acting
Mid-acting
Long-acting
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Hospital
Clinic
Home Usage
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
United States Insulin Market Report 2018
1 Insulin Overview
1.1 Product Overview and Scope of Insulin
1.2 Classification of Insulin by Product Category
1.2.1 United States Insulin Market Size (Sales Volume) Comparison by Type (2013-2025)
1.2.2 United States Insulin Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
1.2.3 Short-acting
1.2.4 Mid-acting
1.2.5 Long-acting
1.3 United States Insulin Market by Application/End Users
1.3.1 United States Insulin Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Home Usage
1.4 United States Insulin Market by Region
1.4.1 United States Insulin Market Size (Value) Comparison by Region (2013-2025)
1.4.2 The West Insulin Status and Prospect (2013-2025)
1.4.3 Southwest Insulin Status and Prospect (2013-2025)
1.4.4 The Middle Atlantic Insulin Status and Prospect (2013-2025)
1.4.5 New England Insulin Status and Prospect (2013-2025)
1.4.6 The South Insulin Status and Prospect (2013-2025)
1.4.7 The Midwest Insulin Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Insulin (2013-2025)
1.5.1 United States Insulin Sales and Growth Rate (2013-2025)
1.5.2 United States Insulin Revenue and Growth Rate (2013-2025)
2 United States Insulin Market Competition by Players/Suppliers
2.1 United States Insulin Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Insulin Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Insulin Average Price by Players/Suppliers (2013-2018)
2.4 United States Insulin Market Competitive Situation and Trends
2.4.1 United States Insulin Market Concentration Rate
2.4.2 United States Insulin Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Insulin Manufacturing Base Distribution, Sales Area, Product Type
3 United States Insulin Sales (Volume) and Revenue (Value) by Region (2013-2018)
3.1 United States Insulin Sales and Market Share by Region (2013-2018)
3.2 United States Insulin Revenue and Market Share by Region (2013-2018)
3.3 United States Insulin Price by Region (2013-2018)
4 United States Insulin Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018)
4.1 United States Insulin Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Insulin Revenue and Market Share by Type (2013-2018)
4.3 United States Insulin Price by Type (2013-2018)
4.4 United States Insulin Sales Growth Rate by Type (2013-2018)
5 United States Insulin Sales (Volume) by Application (2013-2018)
5.1 United States Insulin Sales and Market Share by Application (2013-2018)
5.2 United States Insulin Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities
6 United States Insulin Players/Suppliers Profiles and Sales Data
6.1 Novo Nordisk
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Insulin Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Novo Nordisk Insulin Sales, Revenue, Price and Gross Margin (2013-2018)
6.1.4 Main Business/Business Overview
6.2 Sanofi
6.2.2 Insulin Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Sanofi Insulin Sales, Revenue, Price and Gross Margin (2013-2018)
6.2.4 Main Business/Business Overview
6.3 Eli Lilly
6.3.2 Insulin Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Eli Lilly Insulin Sales, Revenue, Price and Gross Margin (2013-2018)
6.3.4 Main Business/Business Overview
6.4 Bioton
6.4.2 Insulin Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Bioton Insulin Sales, Revenue, Price and Gross Margin (2013-2018)
6.4.4 Main Business/Business Overview
6.5 Dongbao
6.5.2 Insulin Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Dongbao Insulin Sales, Revenue, Price and Gross Margin (2013-2018)
6.5.4 Main Business/Business Overview
6.6 Gan & Lee
6.6.2 Insulin Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Gan & Lee Insulin Sales, Revenue, Price and Gross Margin (2013-2018)
6.6.4 Main Business/Business Overview
6.7 United Laboratories (TUL)
6.7.2 Insulin Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 United Laboratories (TUL) Insulin Sales, Revenue, Price and Gross Margin (2013-2018)
6.7.4 Main Business/Business Overview
...
7 Insulin Manufacturing Cost Analysis
7.1 Insulin Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Insulin
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Insulin Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Insulin Major Manufacturers in 2017
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Insulin Market Size (Value and Volume) Forecast (2018-2025)
11.1 United States Insulin Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Insulin Sales Volume Forecast by Type (2018-2025)
11.3 United States Insulin Sales Volume Forecast by Application (2018-2025)
11.4 United States Insulin Sales Volume Forecast by Region (2018-2025)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Insulin
Figure United States Insulin Market Size (K MT) by Type (2013-2025)
Figure United States Insulin Sales Volume Market Share by Type (Product Category) in 2017
Figure Short-acting Product Picture
Figure Mid-acting Product Picture
Figure Long-acting Product Picture
Figure United States Insulin Market Size (K MT) by Application (2013-2025)
Figure United States Sales Market Share of Insulin by Application in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Home Usage Examples
Table Key Downstream Customer in Home Usage
Figure United States Insulin Market Size (Million USD) by Region (2013-2025)
Figure The West Insulin Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Insulin Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Insulin Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Insulin Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Insulin Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Insulin Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Insulin Sales (K MT) and Growth Rate (2013-2025)
Figure United States Insulin Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Insulin Market Major Players Product Sales Volume (K MT) (2013-2018)
Table United States Insulin Sales (K MT) of Key Players/Suppliers (2013-2018)
Table United States Insulin Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Insulin Sales Share by Players/Suppliers
Figure 2017 United States Insulin Sales Share by Players/Suppliers
Figure United States Insulin Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Insulin Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Insulin Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Insulin Revenue Share by Players/Suppliers
Figure 2017 United States Insulin Revenue Share by Players/Suppliers
Table United States Market Insulin Average Price (USD/MT) of Key Players/Suppliers (2013-2018)
Figure United States Market Insulin Average Price (USD/MT) of Key Players/Suppliers in 2017
Figure United States Insulin Market Share of Top 3 Players/Suppliers
Figure United States Insulin Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Insulin Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Insulin Product Category
Table United States Insulin Sales (K MT) by Region (2013-2018)
Table United States Insulin Sales Share by Region (2013-2018)
Figure United States Insulin Sales Share by Region (2013-2018)
Figure United States Insulin Sales Market Share by Region in 2017
Table United States Insulin Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Insulin Revenue Share by Region (2013-2018)
Figure United States Insulin Revenue Market Share by Region (2013-2018)
Figure United States Insulin Revenue Market Share by Region in 2017
Table United States Insulin Price (USD/MT) by Region (2013-2018)
Table United States Insulin Sales (K MT) by Type (2013-2018)
Table United States Insulin Sales Share by Type (2013-2018)
Figure United States Insulin Sales Share by Type (2013-2018)
Figure United States Insulin Sales Market Share by Type in 2017
Table United States Insulin Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Insulin Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Insulin by Type (2013-2018)
Figure Revenue Market Share of Insulin by Type in 2017
Table United States Insulin Price (USD/MT) by Types (2013-2018)
Figure United States Insulin Sales Growth Rate by Type (2013-2018)
Table United States Insulin Sales (K MT) by Application (2013-2018)
Table United States Insulin Sales Market Share by Application (2013-2018)
Figure United States Insulin Sales Market Share by Application (2013-2018)
Figure United States Insulin Sales Market Share by Application in 2017
Table United States Insulin Sales Growth Rate by Application (2013-2018)
Figure United States Insulin Sales Growth Rate by Application (2013-2018)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Insulin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Novo Nordisk Insulin Sales Growth Rate (2013-2018)
Figure Novo Nordisk Insulin Sales Market Share in United States (2013-2018)
Figure Novo Nordisk Insulin Revenue Market Share in United States (2013-2018)
Table Sanofi Basic Information List
Table Sanofi Insulin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Sanofi Insulin Sales Growth Rate (2013-2018)
Figure Sanofi Insulin Sales Market Share in United States (2013-2018)
Figure Sanofi Insulin Revenue Market Share in United States (2013-2018)
Table Eli Lilly Basic Information List
Table Eli Lilly Insulin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Eli Lilly Insulin Sales Growth Rate (2013-2018)
Figure Eli Lilly Insulin Sales Market Share in United States (2013-2018)
Figure Eli Lilly Insulin Revenue Market Share in United States (2013-2018)
Table Bioton Basic Information List
Table Bioton Insulin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Bioton Insulin Sales Growth Rate (2013-2018)
Figure Bioton Insulin Sales Market Share in United States (2013-2018)
Figure Bioton Insulin Revenue Market Share in United States (2013-2018)
Table Dongbao Basic Information List
Table Dongbao Insulin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Dongbao Insulin Sales Growth Rate (2013-2018)
Figure Dongbao Insulin Sales Market Share in United States (2013-2018)
Figure Dongbao Insulin Revenue Market Share in United States (2013-2018)
Table Gan & Lee Basic Information List
Table Gan & Lee Insulin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Gan & Lee Insulin Sales Growth Rate (2013-2018)
Figure Gan & Lee Insulin Sales Market Share in United States (2013-2018)
Figure Gan & Lee Insulin Revenue Market Share in United States (2013-2018)
Table United Laboratories (TUL) Basic Information List
Table United Laboratories (TUL) Insulin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure United Laboratories (TUL) Insulin Sales Growth Rate (2013-2018)
Figure United Laboratories (TUL) Insulin Sales Market Share in United States (2013-2018)
Figure United Laboratories (TUL) Insulin Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Insulin
Figure Manufacturing Process Analysis of Insulin
Figure Insulin Industrial Chain Analysis
Table Raw Materials Sources of Insulin Major Players/Suppliers in 2017
Table Major Buyers of Insulin
Table Distributors/Traders List
Figure United States Insulin Sales Volume (K MT) and Growth Rate Forecast (2018-2025)
Figure United States Insulin Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Insulin Price (USD/MT) Trend Forecast (2018-2025)
Table United States Insulin Sales Volume (K MT) Forecast by Type (2018-2025)
Figure United States Insulin Sales Volume (K MT) Forecast by Type (2018-2025)
Figure United States Insulin Sales Volume (K MT) Forecast by Type in 2025
Table United States Insulin Sales Volume (K MT) Forecast by Application (2018-2025)
Figure United States Insulin Sales Volume (K MT) Forecast by Application (2018-2025)
Figure United States Insulin Sales Volume (K MT) Forecast by Application in 2025
Table United States Insulin Sales Volume (K MT) Forecast by Region (2018-2025)
Table United States Insulin Sales Volume Share Forecast by Region (2018-2025)
Figure United States Insulin Sales Volume Share Forecast by Region (2018-2025)
Figure United States Insulin Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
